You are here

liver cancer

Roche's Tecentriq scores a first-in-class double win in new liver cancer patients

Fierce Pharma

Mon, 10/21/19 - 04:36 pm

immuno-oncology

Exelixis Hits Blockbuster Status

Motley Fool

Mon, 08/5/19 - 10:45 am

Bristol-Myers star Opdivo fails survival test in a matchup with Nexavar aimed at shaking up the big HCC market

Endpoints

Mon, 06/24/19 - 11:25 am

Bristol-Myers Squibb

clinical trials

Lilly gets fifth use for Cyramza with FDA liver cancer nod

Pharmaforum

Mon, 05/13/19 - 10:07 am

hepatocellular carcinoma

After a delay, Can-Fite digs into subpopulation data as liver cancer drug fails to hit primary endpoint

Fierce Biotech

Wed, 03/27/19 - 11:34 pm

Can-Fite BioPharma

clinical trials

Merck’s PhIII liver cancer study for Keytruda fails on two key endpoints, just three months after the FDA gave it the green light

Endpoints

Tue, 02/19/19 - 07:48 pm

clinical trials

Anti-rejection drug rapamycin shows promise in liver cancer

Fierce Biotech

Fri, 02/1/19 - 10:46 pm

mTOR inhibitors

FDA approves Cabometyx for liver cancer

BioCentury

Mon, 01/14/19 - 11:59 pm

Merck gets FDA okay for Keytruda as liver cancer therapy

Pharmaforum

Mon, 11/12/18 - 09:35 am

hepatocellular carcinoma

Eisai and Merck Announce China Approval of Lenvima for Treatment of Unresectable Hepatocellular Carcinoma

CP Wire

Wed, 09/5/18 - 10:15 am

Eisai and Merck Announce China Approval of Lenvima for Treatment of Unresectable Hepatocellular Carcinoma

Wed, 09/5/18 - 09:25 am

hepatocellular carcinoma

Death rate from liver cancer skyrockets

WWSB

Fri, 08/17/18 - 09:18 pm

Japan's Eisai sets price tag of about $16,000 on liver cancer drug

Yahoo/Reuters

Thu, 08/16/18 - 11:12 pm

FDA stalls Eisai—and its new partner Merck—in quest to widen cancer med Lenvima's reach

Fierce Pharma

Fri, 05/25/18 - 12:15 pm

Lilly's Cyramza succeeds in late-stage liver cancer trial

Yahoo/Reuters

Wed, 04/4/18 - 08:55 am

clinical trials

Bristol-Myers' I-O star Opdivo steps up to challenge Bayer's Stivarga in liver cancer

Fierce Pharma

Mon, 09/25/17 - 11:04 am

Bristol-Myers Squibb

Eisai's Lenvima nabs survival edge in liver cancer showdown with Bayer's Nexavar

Fierce Pharma

Sun, 06/4/17 - 11:51 am

Bayer's Stivarga Shows Slim Progress Against Liver Cancer

Forbes

Thu, 04/27/17 - 05:52 pm

Daiichi, ArQule cancer drug fails in late-stage study

BioPharma Dive

Sat, 02/18/17 - 02:43 pm

clinical trials

Bayer growth hope Stivarga boosts survival in liver cancer patients

Fierce Pharma

Wed, 06/29/16 - 10:50 am

hepatocellular carcinoma

Pages